Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of GX-I7 in Combination With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors

NCT03733587 is registered in ClinicalTrials.gov with Genexine, Inc. as lead sponsor.

NCT NCT03733587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03733587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of GX-I7 in Combination With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors
Lead sponsor
Genexine, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 17, 2018
Completion date
May 13, 2020
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor